Posts by Robin Feldman

Jaime King on California’s Drug Transparency Law

Published on: Author: Robin Feldman

When Governor Jerry Brown signed California’s drug transparency law, Senate Bill 17 (SB-17), in 2017, the state took a crucial first step towards increased transparency and accountability in a landscape of skyrocketing prescription-drug prices. Not only does SB-17 require drug manufacturers and health insurers to disclose information about rising prescription-drug prices, but it also represents… Continue reading

Jaime King on the Anti-Competitive Potential of Cross-Market Mergers in Health Care

Published on: Author: Robin Feldman

What drives health care costs ever higher? Consolidation may be playing a key role. In this context, Professor Jaime King’s contribution to the St. Louis University Annual Health Law Symposium, “The Anti-Competitive Potential of Cross-Market Mergers in Health Care” (coauthored with Erin C. Fuse Brown), is a clarion call for antitrust authorities to consider seriously… Continue reading